Skip to content

Bausch Health Companies BHC Free cash flow margin

Free cash flow margin at other companies

PBH
Prestige Consumer HealthcarePBH
22.6%+1.3pp
Bausch + Lomb logo
Bausch + LombBLCO
-3.4%0.0pp
Johnson & Johnson logo
Johnson & JohnsonJNJ
18.5%-4.3pp
AbbVie logo
AbbVieABBV
31.8%+5.0pp
Organon logo
OrganonOGN
11.1%-1.3pp
HRO
HarrowHROW
5.7%+5.0pp

Other financials

Income statement

See full
Revenue$2.5B+11.7%
Operating income-$950.0M-444%
Net income-$1.4B-2,353%
EPS (diluted)-$3.82-2,287%

Balance sheet

See full
Cash & equivalents$1.3B+13.4%
Total debt$20.8B-3.5%
Total equity-$2.1B-74.0%
Total assets$24.5B-7.3%

Cash flow

See full
Operating cash flow$230.0M+9.0%
CapEx$109.0M-5.2%
Free cash flow$121.0M+26.0%

Valuation

See full
Market cap$1.79B-15.9%
Enterprise value$21.24B-5.6%
P/S0.2×0.0×

Profitability

See full
Gross margin71.4%
Operating margin5.6%-10.3pp
Net margin-1.9%-0.9pp

Returns & leverage

See full
Return on equity-70.1%
Debt / equity45.2×
Current ratio1.3×0.0×

Where this comes from

Calculated from Bausch Health Companies’s reported figures.

Based on trailing twelve months.

The official record: Bausch Health Companies’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Bausch Health Companies's free cash flow margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Bausch Health Companies's free cash flow margin?
Bausch Health Companies (BHC) reported free cash flow margin of 9.8% in Q1 2026.
How has Bausch Health Companies's free cash flow margin changed year-over-year?
Bausch Health Companies's free cash flow margin decreased by 22.6% year-over-year, from 12.6% to 9.8%.
What is the long-term trend for Bausch Health Companies's free cash flow margin?
Over 4 years (2020 to 2025), Bausch Health Companies's free cash flow margin has grown at a -0.8% compound annual growth rate (CAGR), from 10.1% to 9.8%.
What does free cash flow margin mean?
Free cash flow (operating cash flow minus capital expenditures) as a percentage of revenue, trailing twelve months. Measures how efficiently revenue converts into discretionary cash.